Table of Contents
Executive Summary
1 Industry Overview of Herpes Treatment
1.1 Definition of Herpes Treatment
1.2 Herpes Treatment Segment by Type
1.2.1 Global Herpes Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.3 Herpes Treatment Segment by Applications
1.3.1 Global Herpes Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Global Herpes Treatment Overall Market
1.4.1 Global Herpes Treatment Revenue (2014-2025)
1.4.2 Global Herpes Treatment Production (2014-2025)
1.4.3 North America Herpes Treatment Status and Prospect (2014-2025)
1.4.4 Europe Herpes Treatment Status and Prospect (2014-2025)
1.4.5 China Herpes Treatment Status and Prospect (2014-2025)
1.4.6 Japan Herpes Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Herpes Treatment Status and Prospect (2014-2025)
1.4.8 India Herpes Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Herpes Treatment
2.3 Manufacturing Process Analysis of Herpes Treatment
2.4 Industry Chain Structure of Herpes Treatment
3 Development and Manufacturing Plants Analysis of Herpes Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Herpes Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Herpes Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Herpes Treatment Production and Capacity Analysis
4.2 Herpes Treatment Revenue Analysis
4.3 Herpes Treatment Price Analysis
4.4 Market Concentration Degree
5 Herpes Treatment Regional Market Analysis
5.1 Herpes Treatment Production by Regions
5.1.1 Global Herpes Treatment Production by Regions
5.1.2 Global Herpes Treatment Revenue by Regions
5.2 Herpes Treatment Consumption by Regions
5.3 North America Herpes Treatment Market Analysis
5.3.1 North America Herpes Treatment Production
5.3.2 North America Herpes Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Herpes Treatment Import and Export
5.4 Europe Herpes Treatment Market Analysis
5.4.1 Europe Herpes Treatment Production
5.4.2 Europe Herpes Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Herpes Treatment Import and Export
5.5 China Herpes Treatment Market Analysis
5.5.1 China Herpes Treatment Production
5.5.2 China Herpes Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Herpes Treatment Import and Export
5.6 Japan Herpes Treatment Market Analysis
5.6.1 Japan Herpes Treatment Production
5.6.2 Japan Herpes Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Herpes Treatment Import and Export
5.7 Southeast Asia Herpes Treatment Market Analysis
5.7.1 Southeast Asia Herpes Treatment Production
5.7.2 Southeast Asia Herpes Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Herpes Treatment Import and Export
5.8 India Herpes Treatment Market Analysis
5.8.1 India Herpes Treatment Production
5.8.2 India Herpes Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Herpes Treatment Import and Export
6 Herpes Treatment Segment Market Analysis (by Type)
6.1 Global Herpes Treatment Production by Type
6.2 Global Herpes Treatment Revenue by Type
6.3 Herpes Treatment Price by Type
7 Herpes Treatment Segment Market Analysis (by Application)
7.1 Global Herpes Treatment Consumption by Application
7.2 Global Herpes Treatment Consumption Market Share by Application (2014-2019)
8 Herpes Treatment Major Manufacturers Analysis
8.1 Gilead
8.1.1 Gilead Herpes Treatment Production Sites and Area Served
8.1.2 Gilead Product Introduction, Application and Specification
8.1.3 Gilead Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Herpes Treatment Production Sites and Area Served
8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck
8.3.1 Merck Herpes Treatment Production Sites and Area Served
8.3.2 Merck Product Introduction, Application and Specification
8.3.3 Merck Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis
8.4.1 Novartis Herpes Treatment Production Sites and Area Served
8.4.2 Novartis Product Introduction, Application and Specification
8.4.3 Novartis Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Abbott
8.5.1 Abbott Herpes Treatment Production Sites and Area Served
8.5.2 Abbott Product Introduction, Application and Specification
8.5.3 Abbott Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mylan
8.6.1 Mylan Herpes Treatment Production Sites and Area Served
8.6.2 Mylan Product Introduction, Application and Specification
8.6.3 Mylan Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Teva Pharmaceutical Industries
8.7.1 Teva Pharmaceutical Industries Herpes Treatment Production Sites and Area Served
8.7.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
8.7.3 Teva Pharmaceutical Industries Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Vical
8.8.1 Vical Herpes Treatment Production Sites and Area Served
8.8.2 Vical Product Introduction, Application and Specification
8.8.3 Vical Herpes Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Herpes Treatment Market
9.1 Global Herpes Treatment Market Trend Analysis
9.1.1 Global Herpes Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Herpes Treatment Regional Market Trend
9.2.1 North America Herpes Treatment Forecast 2019-2025
9.2.2 Europe Herpes Treatment Forecast 2019-2025
9.2.3 China Herpes Treatment Forecast 2019-2025
9.2.4 Japan Herpes Treatment Forecast 2019-2025
9.2.5 Southeast Asia Herpes Treatment Forecast 2019-2025
9.2.6 India Herpes Treatment Forecast 2019-2025
9.3 Herpes Treatment Market Trend (Product Type)
9.4 Herpes Treatment Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Herpes Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Gilead、GlaxoSmithKline、Merck、Novartis、Abbott、Mylan、Teva Pharmaceutical Industries、Vical